The highly publicized insider trading case against SAC Capital Advisors trader Mathew Martoma has finally come to a conclusion--at least for now. A jury found him guilty in the case in which SAC was said to have reaped $275 million in profits but trading on tips from a clinical researcher that much-hyped Alzheimer's hopeful from Elan ($ELN) and Wyeth, was about to flunk out of clinical development, The New York Times reports. Story | More